- Home
- ELTX vs YGMZ Comparison
ELTX vs YGMZ Comparison
Compare ELTX & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- YGMZ
- Stock Information
- Founded
- ELTX 2011
- YGMZ 2002
- Country
- ELTX United States
- YGMZ China
- Employees
- ELTX N/A
- YGMZ N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- YGMZ Transportation Services
- Sector
- ELTX Health Care
- YGMZ Consumer Discretionary
- Exchange
- ELTX Nasdaq
- YGMZ Nasdaq
- Market Cap
- ELTX 121.7M
- YGMZ 101.2M
- IPO Year
- ELTX N/A
- YGMZ 2020
- Fundamental
- Price
- ELTX $7.10
- YGMZ $1.31
- Analyst Decision
- ELTX Strong Buy
- YGMZ
- Analyst Count
- ELTX 2
- YGMZ 0
- Target Price
- ELTX $9.50
- YGMZ N/A
- AVG Volume (30 Days)
- ELTX 34.8K
- YGMZ 19.3K
- Earning Date
- ELTX 05-13-2025
- YGMZ 01-01-0001
- Dividend Yield
- ELTX N/A
- YGMZ N/A
- EPS Growth
- ELTX N/A
- YGMZ N/A
- EPS
- ELTX N/A
- YGMZ N/A
- Revenue
- ELTX N/A
- YGMZ $40,429,750.00
- Revenue This Year
- ELTX N/A
- YGMZ N/A
- Revenue Next Year
- ELTX N/A
- YGMZ N/A
- P/E Ratio
- ELTX N/A
- YGMZ N/A
- Revenue Growth
- ELTX N/A
- YGMZ N/A
- 52 Week Low
- ELTX $3.34
- YGMZ $0.64
- 52 Week High
- ELTX $9.99
- YGMZ $4.35
- Technical
- Relative Strength Index (RSI)
- ELTX 64.39
- YGMZ 46.77
- Support Level
- ELTX $6.91
- YGMZ $1.22
- Resistance Level
- ELTX $7.94
- YGMZ $1.35
- Average True Range (ATR)
- ELTX 0.50
- YGMZ 0.09
- MACD
- ELTX 0.25
- YGMZ -0.03
- Stochastic Oscillator
- ELTX 73.12
- YGMZ 2.94
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.